How ACO s Can Impact Contracting A Real World Example. Mike Medel Pharm D, MBA Banner Health

Similar documents
Investor Conference. Health Net Pharmaceutical Services

THIRD-PARTY PHARMACY RECONCILIATION

A Unique Vision of Care. Jefferies 2014 Global Healthcare Conference June 3, 2014

Gulf Coast and LA HFMA Payer Summit Value-based contracts same healthcare business?

Risky Business: Crystal Run Health Plans. Michelle A. Koury, MD Jonathan Nasser, MD Crystal Run Healthcare

Meeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark

Standing strong for payers and patients

Assessing ACA Issues - The 40% Excise Tax and Other Employer Implications

A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR EMPLOYERS

Session 75 OF, Advantages & Challenges for Provider Led Health Plans. Moderator: LuCretia Leola Hydell, ASA, MAAA

Fourth Quarter 2018 Earnings Conference Call

Healthcare Purchasing in an Era of Accountable Care: How Will Provider Groups Define and Deliver Value?? What will it take?

How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD

Growth and Success of Accountable Care Organizations (ACOs) in the US from Dennis Horrigan June 2016

MEDICARE ADVANTAGE MA Plans. to $28 per month 46% HOW HEALTH SYSTEMS CAN THRIVE WITH. Developing Your Medicare Advantage Strategy PRODUCT

Pharmacy Benefit Managers Overview

The Emergence of Value-Based Care: Present and Future Tense

Insightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management.

Will Health Plans Kill the Laboratory Outreach Program?

MEDICARE PART D PRESCRIPTION DRUG EVENTS (PDE) RECONCILIATION

Quarterly Report As of December 31, 2018 and for the three and six months ended December 31, 2018

Employee Benefit Trends and Strategies

Standing strong for payers and patients

PATH TOWARD PAYMENTS THAT REWARD VALUE

Challenges in High Dollar Drugs. Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare

CBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting

Pharmacy Benefit Management in Oncology

A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR GOVERNMENT

The Real-Time Benefit Check Key to Closing the Gaps in Eligibility Driven Formulary. Tony Schueth Chief Executive Officer & Managing Partner

SelectHealth Prescriptions

Approved Models to Align Incentives between Hospitals and their Physicians

Delivering Value for All Health Care Stakeholders. Larry Merlo President & Chief Executive Officer

Building an Effective Reimbursement System. Population Based Reimbursement: Introduction. The Challenge. David Axene, FSA, FCA, CERA, MAAA

Allscripts Healthcare Solutions Investor Presentation. September 2018

Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry

The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD

9/23/2016. Our Services. Transitioning from Fee-for-Service to Value-based Reimbursement. Key Trends and Strategies for Rural Health Providers

The Health Management Academy Strategic Survey Q1 2019: Defining Risk. March 2019

Non-Profit Health Care Investor Conference. SSM Health Care May 22, 2014

Unique PBM Capabilities

Pharmacy Trend Management

Innovative Strategies for Managing the Rising Cost of Specialty Drugs

Magellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017

Real-Time Benefit Check (RTBC) Solution Assessment. Requirements for selecting the most valuable RTBC solution for your health system

HealthFlex Vendor and Administrative Updates

Growth in an Evolving Health Care Market

AFFORDABILITY REVIEW. Mysteries of the Medical Loss Ratio

The Real Deal About Real-Time Benefits. Proven Savings with Up-to-the-Minute, Member-Specific Information Across Multiple Points of Care

Modeling Price Increases and the Effects on Customer Segments

Steve Liles, PharmD Senior Director, Value Based Purchasing Magellan Medicaid Administration

Consumers Union Health Care Value Hub

SPECIALTY PHARMA DRIVING THE EMERGENCE OF ACCESS HUBS FOR PRIVATE PAYERS

The Management of Specialty Drugs: Opportunities and Challenges

What May Self-Insured Employers do to Impact Specialty Pharmaceuticals Benefit, Cost and Trend?

Medicare Congress: Fee for Service Trends: A Look at Medicare Part B

THE FAST AND THE FURIOUS REVENUE CYCLE (A.K.A.) THE REVENUE CYCLE OF THE FUTURE

10 Best Practices For Payer Contracting:

10 Best Practices For Payer Contracting: A Roadmap for Successful Negotiations

Pharmacy Benefit Managers (PBMs)

THE 2015 GENENTECH ONCOLOGY TREND REPORT

A Payor and Provider s Perspective on Drug Pricing. Sharon Levine, MD Executive Vice President, The Permanente Federation

Earnings Conference Call

Payer Channel Forecasting and Analysis. Patrick J. Park, PharmD, MBA Director, Business Decision Support Daiichi Sankyo, Inc.

Aetna Whole Health SM Brochure

Medicare Part D Prescription Drug Plan

ProCare Rx - History ProCare Rx founded as a Healthcare Information Technology Company

4/27/2017. Best Practices for Assessing the Feasibility of New Business Opportunities. Financial Disclosure. Course Agenda

Inside: Critical information about your company s prescription drug benefit.

Q SPECIAL TOPIC REPORT: PROVIDER-OWNED HEALTH PLANS

Health Care Compliance Association: Medicare Part D Compliance Conference

IT TAKES THREE TO TANGO

The Case For Value ACA to MACRA to MIPS

Contract Summary. OptumRx Administrative Services, LLC

Under Construction: At the Crossroads of Volume and Value. Session PCM1, February 19, 2017 David Smith, Chief Development Officer, Leavitt Partners

Medicare s s 2009 eprescribing Program

Session 64PD, Risk-Sharing Arrangements in Medicare Advantage

June Investor Presentation

Overview of Coverage of Drugs Under the Medicaid Medical Benefit

Providers Contracting Directly With Employers

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS

Disclosures. Objectives INTRODUCTION 11/18/2015. I have no Disclosures

GMCB Update Health Reform Oversight Committee. Chair Kevin Mullin and Michael Barber October 25, 2018

Savings Generated by New York s Medicaid Pharmacy Reform

Society of Professors of Child and Adolescent Psychiatry. Michael Jellinek, M.D. May 9, 2013

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

Share a Clear View. Vanderbilt University

Excellus BlueCross BlueShield Participating Provider Manual. 5.0 Pharmacy Management

Maximizing Hometown Health Care Performance

Problems with Current Health Plans

COMPASS ROSE HEALTH PLAN PROTECTING OUR MEMBERS SINCE 1948

Moving to Value with a Population Health Services Organization

MANAGED CARE : THEN, NOW AND TOMORROW

37 th Annual J.P. Morgan Healthcare Conference January 9, 2019

Understanding Your Prescription Program. CCIU Employee Meeting September 7, 2016

Marc Claussen, Chiesi USA, Director, Market Access. Donna White, Chiesi USA, Sr. Director, Contracting and Compliance

Health Service Board Rates and Benefits Committee Meeting

PHARMACY BENEFIT MANAGER (PBM)

Best Practice Recommendation for

Get the most out of your pharmacy benefit.

Transcription:

How ACO s Can Impact Contracting A Real World Example Mike Medel Pharm D, MBA Banner Health

Agenda Banner Pharmacy Services Introduction Accountable Care Organization Summary Basic Constructs of ACO Partnership Division of Responsibilities in an ACO

Banner Pharmacy Services Vision Statement Banner Pharmacy Services will be recognized nationally as a clinical leader and trusted partner in providing innovative pharmacy services and coordinated patient care through convenient access and improved medication outcomes across the continuum.

Banner Pharmacy Benefit Management History and Vision Large Traditional PBM 2013 Smaller PBM (Alignment) 2015 Banner Health Integrated Pharmacy Program 2018 Standard formulary Standard clinical programs Standard benefit design Standard Network PBM Home Delivery PBM Specialty Pharmacy Custom Home Delivery Specialty Pharmacy Semi-Custom Benefit Design Formulary Clinical programs Network Customized formulary Customized clinical programs Customized Network Customized benefit designs Continue Home Delivery Continue Specialty Pharmacy Fast Facts: The traditional PBM business model is misaligned with at risk payers BPS strategy is completely aligned with Banner Plan strategy

Accountable Care Organizations Payer/Provider Joint Venture Goals Multi-System (Super ACO) Medicare Shared Savings Program (MSSP) Improve care coordination Improve quality Improve costs Accountable Care Organization Payers Providers

General Payer Partnership Goals Provide Quality Care Application of recognized clinical guidelines Providers integrated into limited (or one) EHR Consumer Friendly Product Easy access points to care and information Many provider choices Multiple ways to access care Low out of pocket costs Efficient Cost of Care Network Strategy Appropriate provider/member incentives Formulary development with appropriate utilization management Successful Partnership

Types of Workgroups in a Payer/Provider Collaboration Leadership Team Go to Market Strategy Differentiation Population Health/Clinical Oversight Corporate Structure Product *(plan design) Network Marketing Sales Digital Sales Pharmacy Multidisciplinary Care Team (MDCT) Pharmacy Licensure Finance/Accounting Ancillary Legal Review/Contracts Clinical Savings Team Specialty Pharmacy DOPR Division Of Pharmacy Responsibility

Flow of Funds in a Shared Premium Relationship Example JV collects $100 in monthly premium Generally: Cost of care is a Provider function Cost of operations is a Payer function Cost of Care = ($45) Cost of Operations = ($35) $20 left over which is split 49% 51% * Financials are for example only Provider $9.80 Payer $10.20

Flow of Funds in a Shared Premium Relationship Rx Example JV collects $100 in monthly premium Cost of Care = ($45) Cost of Operations = ($35) $20 left over 49% which is split 51% Provider $9.80 Payer $10.20 Margin lost to PBM Cost of Care = $45* 25% = Pharmacy Costs ($11.25) 10% Margin from drug costs ($1.13) No financial benefit to partnership Payer own/relationship with Pharmacy Provider $10.20 + $1.13 = $11.33 Plan should put additional margin into the amount split Payer/PBM could end up with additional 3% which may not sound like much but a mid-size MA plan with membership of 50,000 members can spend over $100,000,000 on outpatient drugs. * Financials are for example only

Payer/Provider Partnership Misalignment vs. Traditional PBM Payer/Provider Partnership Goals Consumer Friendly Easy to understand pricing Quality Care Right drug Right patient Right time Lower Cost Provide lowest cost drug to solve clinical issue Traditional PBM Goals Increase claim volume Increase home delivery margin Increase specialty margin Increase rebate margin Push to higher cost products

Traditional and Optimal Plan/Payer Partnerships Traditional Partnership Health System Payer Health System Optimal Partnership Payer VS. Home Delivery Retail Pharmacy Prescriber UM Manufacturer Rebates Plan Design Strategy Specialty Pharmacy Formulary Management Retail Pharmacy Benefit Operations Manufacturer Rebates Plan Design Strategy Network Management Formulary Management

Division of Pharmacy Responsibility - DOPR DOPR The document negotiated between the health plan partner and health system that assigns responsibility for the strategy, development and execution of tasks relating to the management of pharmacy component of a risk arrangement. The DOPR will be part of the final Agreement. Highlights ~100 individual items Clinical PBM Specialty Pharmacy Provider Home Delivery Provider Retail Network Collaborate on plan design offered to market Data sharing

ACO Pharmacy Contracting Summary Specialty Pharmacy ACO Partnership Provider (Pharmacy Dept.) Retail Pharmacy Rebates Mail Order Pharmacy Data and Analytics PBM Payer (Insurer) Ambulatory Infusion Clinical Programs